Hi:  Pardon our mess as we upgraded our site.  

Now, onto more important things, such as the buzz surrounding the updated PhRMA guidelines for interactions with healthcare professionals.  Here are two major concerns:  1.  Will much really change with this new guidance document?  2.  CME funding has already been declining, or at least it has from the pharmacy continuing education side.  While it is understood that influence should not occur by funding companies regarding content on CME programs, how far is the industry going to go in assisting medical education endeavors?  These questions are worth considering…even as a MSL.